Fact CheckerSign in

NCT07741266Not yet recruiting

Effects of a Large Language Model-Driven Chatbot on Reproductive Concerns After Cancer

The Feasibility and Preliminary Effectiveness of a Large Language Model-Driven Chatbot in Addressing Reproductive Concerns Among Adolescent and Young Adult Cancer Survivors: A Pilot Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 3 Aug 2026

Brief summary (registry, in English)

Reproductive health has emerged as a critical yet overlooked concern among Adolescent and Young Adult (AYA) cancer survivors, given their compromised potential for biological parenthood in prime childbearing years. Large language models (LLMs) offer a promising solution to bridge onco-fertility service gaps by integrating evidence-based knowledge and therapeutic frameworks. This pilot randomized controlled trial aims to assess the feasibility and preliminary effectiveness of an LLM-driven chatbot versus electronic brochure in addressing reproductive concerns among AYA cancer survivors.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
60 (estimated)
First submitted
28 Jul 2026
Start date
1 Sept 2026
Primary completion date
30 Jun 2027
Lead sponsor
The Hong Kong Polytechnic University
NCT number
NCT07741266

What you commit to

  • Study type: Interventional
  • Planned participants: 60
  • From 1 Sept 2026 to the primary completion date, 30 Jun 2027
  • 2 sites in 2 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • (1) Involvement in the chatbot co-design phases; (2) inability to provide informed consent; (3) significant sensory, cognitive, or psychological impairments precluding meaningful participation; and (4) acute illness at the time of recruitment.

Who the study is looking for

  • (1) 15-39-year-old females; (2) cancer diagnosis between ages 15-39; (3) current or prior concerns regarding fertility; (4) proficiency in Mandarin Chinese; and (5) access to a mobile device for intervention delivery.

Age in the registry: 15 years to 39 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
The University of Science and Technology of China
Coordinator of this site? Confirm its status
HefeiChinaUnknown status
The Hong Kong Polytechnic University
Coordinator of this site? Confirm its status
KowloonHong Kong SAR ChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.